Home/Filings/4/0001231919-06-000117
4//SEC Filing

REPLIDYNE INC 4

Accession 0001231919-06-000117

CIK 0001180145operating

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 12:52 PM ET

Size

21.5 KB

Accession

0001231919-06-000117

Insider Transaction Report

Form 4
Period: 2006-07-03
Transactions
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
Transactions
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
Transactions
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
Transactions
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
Transactions
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
AGUIAR ERIC
10% Owner
Transactions
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
Transactions
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
Transactions
  • Conversion

    Series A Convertible Preferred

    2006-07-038,250,3000 total(indirect: and Direct)
    Exercise: $0.00Common Stock (8,250,300 underlying)
  • Conversion

    Series C Convertible Preferred

    2006-07-037,280,0010 total(indirect: and Direct)
    Exercise: $0.00Common Stock (7,280,001 underlying)
  • Conversion

    Common Stock

    2006-07-03+3,166,8633,463,102 total(indirect: and Direct)
Footnotes (5)
  • [F1]Not Applicable
  • [F2]Includes 296,239 shares of the Issuer's common stock issued to HealthCare Ventures VI, L.P. ("HCVVI") in satisfaction of accumulated dividends on the Reporting Person's Series A and Series C Convertible Preferred Stock.
  • [F3]These securities are owned by HCVVI. These securities are indirectly beneficially owned by HealthCare Partners VI, L.P. ("HCPVI"), the General Partner of HCVVI, and each of James Cavanaugh, Harold Werner, John Littlechild, Christopher Mirabelli, Augustine Lawlor, William Crouse and Eric Aguiar, the general partners of HCPVI. Drs. Cavanaugh, Mirabelli and Aguiar and Messrs. Werner, Littlechild, Crouse and Lawlor disclaim beneficial ownership of those securities in which they do not have a pecuniary interest and this report shall not be deemed an admission that they are the beneficial owners of these securities for purposes of Section 16 except to the extent of their pecuniary interest therein.
  • [F4]These securities automatically converted into 1,682,361 shares of the Issuer's Common Stock on July 3, 2006, the closing of the initial public offering of the Issuer. The conversion of the Series A Convertible Preferred Stock gives effect to the Issuer's 1 for 4.904 reverse stock split.
  • [F5]These securities automatically converted into 1,484,502 shares of the Issuer's Common Stock on July 3, 2006, the closing of the initial public offering of the Issuer. The conversion of the Series C Convertible Preferred Stock gives effect to the Issuer's 1 for 4.904 reverse stock split.

Issuer

REPLIDYNE INC

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 12:52 PM ET
Size
21.5 KB